메뉴 건너뛰기




Volumn 28, Issue 1, 2001, Pages 95-101

Phase I clinical trial of a monoclonal antibody against CD40-ligand (IDEC-131) in patients with systemic lupus erythematosus

Author keywords

CD40l (CD154) antigen; Monoclonal antibody; Pharmacokinetics; Systemic lupus erythematosus

Indexed keywords

CD40 LIGAND MONOCLONAL ANTIBODY; GLYCOPROTEIN GP 39; MONOCLONAL ANTIBODY IDEC 131; UNCLASSIFIED DRUG;

EID: 0035163042     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (157)

References (19)
  • 4
  • 18
    • 0031229830 scopus 로고    scopus 로고
    • Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [letter]
    • (1997) Arthritis Rheum , vol.40 , pp. 1725
    • Hochberg, M.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.